Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure guided lead generation for M. tuberculosis thymidylate kinase (Mtb TMK): discovery of 3-cyanopyridone and 1,6-naphthyridin-2-one as potent inhibitors.

Journal of medicinal chemistry·2014
Same author

Meeting report: 1st international functional metagenomics workshop may 7-8, 2012, st. Jacobs, ontario, Canada.

Standards in genomic sciences·2013
Same author

Electron self-exchange activation parameters of diethyl sulfide and tetrahydrothiophene.

Beilstein journal of organic chemistry·2013
Same author

NMR backbone assignments of the tyrosine kinase domain of human fibroblast growth factor receptor 1.

Biomolecular NMR assignments·2013
Same author

Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation.

Journal of medicinal chemistry·2012
Same author

MDM4 binds ligands via a mechanism in which disordered regions become structured.

FEBS letters·2010
Same journal

Forensic toxicology.

EXS·2010
Same journal

Biological warfare agents.

EXS·2010
Same journal

Chemical warfare agents.

EXS·2010
Same journal

Drugs of abuse: management of intoxication and antidotes.

EXS·2010
Same journal

Biological testing for drugs of abuse.

EXS·2010
Same journal

Inhalation toxicology.

EXS·2010
See all related articles

Related Experiment Video

Updated: Jan 18, 2026

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

3.8K

NMR-based screening methods for lead discovery.

Martin Vogtherr1, Klaus Fiebig

  • 1Institut für Organische Chemie, Johann-Wolfgang von Goethe-Universität Frankfurt/Main, Marie-Curie Str. 11, D-60431 Frankfurt, Main, Germany.

EXS
|March 5, 2003
PubMed
Summary
This summary is machine-generated.

Nuclear Magnetic Resonance (NMR) based screening offers diverse and robust methods for drug discovery, identifying medium affinity ligands. Advances in NMR technology are making these techniques high-throughput and valuable for structural insights.

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.4K
Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

8.7K

Related Experiment Videos

Last Updated: Jan 18, 2026

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

3.8K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.4K
Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

8.7K

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Structural Biology

Background:

  • Nuclear Magnetic Resonance (NMR) based screening is increasingly vital in drug discovery.
  • NMR techniques offer robust and diverse approaches for identifying potential drug candidates.
  • These methods provide detailed structural information crucial for drug design.

Purpose of the Study:

  • To review and compare various NMR-based screening methods for drug discovery.
  • To highlight the applicability and limitations of different NMR techniques for various targets.
  • To discuss the potential of NMR screening as a high-throughput method.

Main Methods:

  • Structure-Activity Relationship by NMR (SAR by NMR) for small protein targets.
  • 15N-1H-TROSY and 15N-1H-HSQC based screening for protein targets.
  • Ligand-based NMR screening methods for targets of any size.
  • Transfer NOE and isotope-filtered NOESY for ligand conformation and binding site information.

Main Results:

  • SAR by NMR is effective for targets < 30 kDa, providing binding site location.
  • 15N-1H-HSQC screening, enhanced by cryo-cooled probes, is now a high-throughput method.
  • Ligand-based NMR screening detects ligands with millimolar to micromolar affinities and can be used as a prescreening tool.
  • NMR provides detailed structural data, connecting experimental screening with computational drug design.

Conclusions:

  • NMR-based screening is a powerful and versatile tool in modern drug discovery.
  • Advancements in NMR instrumentation are enabling high-throughput screening capabilities.
  • NMR's ability to provide detailed structural information aids in ligand design and optimization.